Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

SELL
$0.21 - $5.63 $155 - $4,166
-740 Reduced 1.98%
36,665 $9,000
Q3 2022

Nov 14, 2022

SELL
$0.46 - $6.75 $528 - $7,749
-1,148 Reduced 2.98%
37,405 $15,000
Q2 2022

Aug 12, 2022

SELL
$0.27 - $0.61 $38,426 - $86,815
-142,320 Reduced 78.69%
38,553 $19,000
Q1 2022

May 12, 2022

SELL
$0.5 - $0.88 $3,816 - $6,716
-7,632 Reduced 4.05%
180,873 $105,000
Q4 2021

Feb 10, 2022

BUY
$0.58 - $1.09 $12,824 - $24,102
22,112 Added 13.29%
188,505 $109,000
Q3 2021

Nov 09, 2021

BUY
$0.93 - $1.18 $31,060 - $39,409
33,398 Added 25.11%
166,393 $188,000
Q2 2021

Aug 11, 2021

BUY
$1.19 - $2.06 $158,264 - $273,969
132,995 New
132,995 $158,000

Others Institutions Holding ECOR

About electroCore, Inc.


  • Ticker ECOR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 71,176,896
  • Market Cap $1.12B
  • Description
  • electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults....
More about ECOR
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.